RENB

RENB

USD

Renovaro Inc. Common Stock

$1.420+0.230 (19.328%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.190

Haut

$1.420

Bas

$1.420

Volume

0.12M

Fondamentaux de l'Entreprise

Capitalisation Boursière

33.8M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.22M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.11Actuel $1.420Haut $21

Actualités Connexes

AccessWire

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550 Regarding Minimum Bid Price LOS ANGELES, CA / ACCESS Newswire / September 24, 2025 / Lunai Bioworks, Inc. ("Lunai Bioworks" or the

Voir plus
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split
AccessWire

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

BETHESDA, MD / ACCESS Newswire / September 11, 2025 / Lunai Bioworks Inc.'s wholly-owned subsidiary BioSymetrics Inc. today announced the award of a prestigious Small Business Technology Transfer

Voir plus
Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics
AccessWire

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Lunai Bioworks Inc. , an AI-powered drug

Voir plus
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
AccessWire

Lunai Bioworks Strengthens European Strategy Through Restructuring

Company remains committed to Europe with a streamlined, growth-focused approach. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 8, 2025 / Lunai Bioworks Inc. , an AI-powered drug discovery and

Voir plus
Lunai Bioworks Strengthens European Strategy Through Restructuring

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.